Pfizer Revenue 2006-2021 | PFE

Pfizer annual/quarterly revenue history and growth rate from 2006 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Pfizer revenue for the quarter ending June 30, 2021 was $18.977B, a 92.39% increase year-over-year.
  • Pfizer revenue for the twelve months ending June 30, 2021 was $55.520B, a 59.83% increase year-over-year.
  • Pfizer annual revenue for 2020 was $41.908B, a 1.79% increase from 2019.
  • Pfizer annual revenue for 2019 was $41.172B, a 0.85% increase from 2018.
  • Pfizer annual revenue for 2018 was $40.825B, a 22.31% decline from 2017.
Pfizer Annual Revenue
(Millions of US $)
2020 $41,908
2019 $41,172
2018 $40,825
2017 $52,546
2016 $52,824
2015 $48,851
2014 $49,605
2013 $51,584
2012 $54,657
2011 $61,035
2010 $65,165
2009 $49,269
2008 $48,296
2007 $48,418
2006 $48,371
2005 $47,405
Pfizer Quarterly Revenue
(Millions of US $)
2021-06-30 $18,977
2021-03-31 $14,582
2020-12-31 $9,830
2020-09-30 $12,131
2020-06-30 $9,864
2020-03-31 $10,083
2019-12-31 $2,110
2019-09-30 $12,680
2019-06-30 $13,264
2019-03-31 $13,118
2018-12-31 $1,155
2018-09-30 $13,298
2018-06-30 $13,466
2018-03-31 $12,906
2017-12-31 $13,703
2017-09-30 $13,168
2017-06-30 $12,896
2017-03-31 $12,779
2016-12-31 $13,627
2016-09-30 $13,045
2016-06-30 $13,147
2016-03-31 $13,005
2015-12-31 $14,047
2015-09-30 $12,087
2015-06-30 $11,853
2015-03-31 $10,864
2014-12-31 $13,118
2014-09-30 $12,361
2014-06-30 $12,773
2014-03-31 $11,353
2013-12-31 $13,558
2013-09-30 $12,643
2013-06-30 $12,973
2013-03-31 $12,410
2012-12-31 $12,851
2012-09-30 $12,953
2012-06-30 $13,968
2012-03-31 $14,885
2011-12-31 $11,439
2011-09-30 $16,609
2011-06-30 $16,485
2011-03-31 $16,502
2010-12-31 $15,462
2010-09-30 $15,995
2010-06-30 $17,132
2010-03-31 $16,576
2009-12-31 $15,797
2009-09-30 $11,621
2009-06-30 $10,984
2009-03-31 $10,867
2008-12-31 $12,346
2008-09-30 $11,973
2008-06-30 $12,129
2008-03-31 $11,848
2007-12-31 $12,870
2007-09-30 $11,990
2007-06-30 $11,084
2007-03-31 $12,474
2006-12-31 $12,603
2006-09-30 $12,280
2006-06-30 $11,741
2006-03-31 $11,747
2005-12-31 $11,599
2005-09-30 $11,263
2005-06-30 $11,452
2005-03-31 $13,091
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $246.358B $41.908B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $432.675B 18.00
Novo Nordisk (NVO) Denmark $237.128B 32.91
Eli Lilly (LLY) United States $222.187B 28.85
AbbVie (ABBV) United States $189.212B 9.07
Merck (MRK) United States $186.335B 12.76
Novartis AG (NVS) Switzerland $185.493B 13.78
GlaxoSmithKline (GSK) United Kingdom $103.369B 12.97